Walk into any hospital wing in the United States and watch a nurse sign in. They will tap a badge, enter a password, click through a session timeout, then repeat the ritual across an electronic health record, a medication dispensing system, an imaging viewer, a secure messaging app, and a scheduling tool. The patient population most affected by this is everyone: every admitted inpatient, every outpatient in a clinic visit, every emergency department arrival whose care is paced, in part, by how quickly the clinician in front of them can authenticate into the next system. The disease state is not one disease. It is the friction that sits between a trained clinician and the chart.
That friction is the wedge Italic Health, a Miami-based startup founded in 2025, is trying to drive into. The company describes itself as building the identity and memory layer for healthcare, starting with what it calls AI-native single sign-on [Italic Health]. Founder and CEO Kyle Michelson is running the company at pre-seed stage [PitchBook]. The pitch, as articulated on the company's site, is narrow at the entry point (sign-on) and broad in ambition (an identity and memory substrate that other clinical AI tools could eventually sit on top of).
The bet
Single sign-on in healthcare is not a new category. Imprivata has dominated the badge-tap workflow in hospitals for years, and Microsoft Entra and Okta both sell into health systems. What Italic appears to be wagering is that the arrival of clinical AI agents (ambient scribes, coding copilots, prior-authorization bots, inbox triagers) creates a new identity problem that legacy SSO was not designed for. When an AI agent acts on behalf of a clinician inside an EHR, who is the principal? What scopes does the agent inherit? What is remembered across sessions, and what is scrubbed? Framing SSO as the substrate for that question, rather than as a password vault, is the interesting part of the bet.
The standard of care today, to borrow a clinical phrase, is a patchwork. Most large health systems run Imprivata or an equivalent for tap-and-go authentication, federated through Active Directory or Entra, with EHR-specific context management layered on top via the CCOW standard. Smaller clinics often rely on shared workstations and shared logins, a practice that auditors flag and that HIPAA enforcement actions have repeatedly cited. Newer AI tools (ambient documentation vendors, for example) typically bolt on through OAuth or SMART on FHIR, with each vendor handling identity slightly differently. There is no consensus identity layer for AI agents acting inside clinical environments. That is the gap Italic is pointing at.
Why it could be big
The tailwind here is real and it is not speculative. Vertical AI in healthcare drew significant investor attention through 2025, with NVP Capital's year-end review describing the period as the deployment era for vertical AI [NVP Capital]. As ambient scribes from Abridge, Nuance DAX, and others move from pilots to enterprise rollouts, the operational questions about how those agents authenticate, how they persist context, and how they comply with audit requirements become first-order procurement concerns for chief information security officers at health systems. A company that owns the identity layer at the moment those questions get asked has structural use.
The upside scenario, if Italic executes, looks like this: an SSO product that lands in mid-market health systems on the strength of a cleaner integration story for AI tools, then expands into a broader identity and memory platform that AI vendors integrate with rather than reinvent. That is a credible category. Whether Italic specifically can occupy it depends on factors that are not yet visible in the public record.
The team
Kyle Michelson is the sole founder and CEO [PitchBook] [RocketReach]. His prior operating experience includes Getlabs, the at-home medical labs company that raised a $3 million seed in 2021 and a $20 million Series A in 2022 [TechCrunch, 2021] [TechCrunch, 2022]. Before that, he was part of Streamup, a Y Combinator W16 company [Y Combinator] [RocketReach]. The Getlabs background matters here: building a logistics and identity-sensitive product that touched patient blood draws inside the home is a credential that translates reasonably well to selling identity infrastructure into health system IT.
| Michelson timeline | Year | Source |
|---|---|---|
| Streamup, Y Combinator W16 | 2016 | Y Combinator |
| Getlabs seed round | 2021 | TechCrunch |
| Getlabs Series A ($20M) | 2022 | TechCrunch |
| Italic Health founded | 2025 | PitchBook |
The honest counterfactual
What bears will say is straightforward. Healthcare identity is a market with deep incumbents, long sales cycles measured in quarters, not weeks, and a procurement gauntlet that includes security reviews, HIPAA business associate agreements, and integration testing against EHR vendors who control the relationship with the customer. A pre-seed solo founder going after Imprivata's installed base is taking on a multi-year build with a capital intensity that the current funding posture, which is undisclosed publicly, will need to match. What bulls answer is that the AI agent identity problem is genuinely new, that incumbents have shown limited urgency in addressing it, and that Michelson's Getlabs experience suggests he understands how to sell into health system operations rather than only into innovation budgets. Both views can be true at once.
What to watch
The next twelve months for Italic come down to three questions. Does the company close a priced seed round with a healthcare-literate lead investor, which would signal that the identity-layer thesis has institutional backing beyond the founder's own conviction? Does it announce a first design partner, ideally a named health system or a clinical AI vendor that would integrate Italic as its identity provider? And does the product itself, currently described in broad strokes on the company site, ship something specific enough that CISOs can evaluate it against Imprivata and Entra on technical merit? Any one of those would meaningfully change the read on the company. None of them have happened yet, and that is the appropriate posture for a company founded earlier this year.
The patient, in the end, is the lede. If Italic shaves seconds off every clinician login and gives AI agents a clean identity to act under, the downstream effect shows up in how much time a nurse spends with a patient versus a screen. That is the outcome worth tracking.
Pulse Raman, Health and Bio Correspondent, Startuply.